March 29 (Reuters) – US health officials on Tuesday authorized a second COVID-19 booster dose of the two most commonly used COVID-19 vaccines for people age 50 and older, citing data showing waning immunity and the risks posed by Omicron variants of the virus. The US Food and Drug Administration agency said the new boosters […]